Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Outstanding
Ratios

Alaunos Therapeutics (TCRT) Long-Term Debt Repayments (2022 - 2023)

Historic Long-Term Debt Repayments for Alaunos Therapeutics (TCRT) over the last 2 years, with Q2 2023 value amounting to $11.9 million.

  • Alaunos Therapeutics' Long-Term Debt Repayments changed N/A to $11.9 million in Q2 2023 from the same period last year, while for Mar 2024 it was $11.9 million, marking a year-over-year decrease of 1870.67%. This contributed to the annual value of $18.1 million for FY2023, which is 11726.87% up from last year.
  • Alaunos Therapeutics' Long-Term Debt Repayments amounted to $11.9 million in Q2 2023.
  • Alaunos Therapeutics' 5-year Long-Term Debt Repayments high stood at $11.9 million for Q2 2023, and its period low was $2.1 million during Q3 2022.